Tal Zvi Zaks insider trades: Teva Pharmaceutical Industries (TEVA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tal reports to the SEC
Open-market buys and sales
72 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | TEVA | ↓ Sell | 17 | $34.87 | $593 | Direct | Aug 10, 2026 (5d) |
| Jun 30, 2021 | MRNA | ↓ Sell | 5,000 | $237.00 | $1.2M | Direct | Jul 2, 2021 (2d) |
| Jun 23, 2021 | MRNA | ↓ Sell | 5,000 | $219.65 | $1.1M | Direct | Jun 25, 2021 (2d) |
| Jun 16, 2021 | MRNA | ↓ Sell | 5,000 | $200.00 | $1.0M | Direct | Jun 21, 2021 (5d) |
| Jun 9, 2021 | MRNA | ↓ Sell | 5,000 | $212.30 | $1.1M | Direct | Jun 11, 2021 (2d) |
| Jun 2, 2021 | MRNA | ↓ Sell | 5,000 | $183.90 | $920K | Direct | Jun 3, 2021 (1d) |
| May 26, 2021 | MRNA | ↓ Sell | 5,000 | $168.70 | $844K | Direct | May 27, 2021 (1d) |
| May 19, 2021 | MRNA | ↓ Sell | 5,000 | $155.74 | $779K | Direct | May 20, 2021 (1d) |
| May 12, 2021 | MRNA | ↓ Sell | 5,000 | $154.11 | $771K | Direct | May 13, 2021 (1d) |
| May 10, 2021 | MRNA | ↓ Sell | 3,670 | $158.48 | $582K | Direct | May 11, 2021 (1d) |
| May 3, 2021 | MRNA | ↓ Sell | 5,000 | $186.46 | $932K | Direct | May 4, 2021 (1d) |
| Apr 26, 2021 | MRNA | ↓ Sell | 5,000 | $175.89 | $879K | Direct | Apr 27, 2021 (1d) |
| Apr 19, 2021 | MRNA | ↓ Sell | 5,000 | $163.05 | $815K | Direct | Apr 20, 2021 (1d) |
| Apr 12, 2021 | MRNA | ↓ Sell | 5,000 | $138.96 | $695K | Direct | Apr 13, 2021 (1d) |
| Apr 5, 2021 | MRNA | ↓ Sell | 5,000 | $129.71 | $649K | Direct | Apr 6, 2021 (1d) |
| Mar 22, 2021 | MRNA | ↓ Sell | 1,199 | $144.82 | $174K | Direct | Mar 23, 2021 (1d) |
| Mar 15, 2021 | MRNA | ↓ Sell | 10,034 | $140.68 | $1.4M | Direct | Mar 16, 2021 (1d) |
| Mar 8, 2021 | MRNA | ↓ Sell | 16,478 | $128.59 | $2.1M | Direct | Mar 10, 2021 (2d) |
| Mar 1, 2021 | MRNA | ↓ Sell | 10,000 | $150.45 | $1.5M | Direct | Mar 2, 2021 (1d) |
| Feb 22, 2021 | MRNA | ↓ Sell | 5,000 | $164.84 | $824K | Direct | Feb 24, 2021 (2d) |
| Feb 8, 2021 | MRNA | ↓ Sell | 3,670 | $184.56 | $677K | Direct | Feb 9, 2021 (1d) |
| Feb 1, 2021 | MRNA | ↓ Sell | 5,000 | $162.34 | $812K | Direct | Feb 2, 2021 (1d) |
| Jan 25, 2021 | MRNA | ↓ Sell | 5,000 | $143.12 | $716K | Direct | Jan 26, 2021 (1d) |
| Jan 19, 2021 | MRNA | ↓ Sell | 5,000 | $123.88 | $619K | Direct | Jan 20, 2021 (1d) |
| Jan 11, 2021 | MRNA | ↓ Sell | 5,000 | $117.12 | $586K | Direct | Jan 12, 2021 (1d) |
| Jan 4, 2021 | MRNA | ↓ Sell | 5,000 | $109.33 | $547K | Direct | Jan 5, 2021 (1d) |
| Dec 28, 2020 | MRNA | ↓ Sell | 1,200 | $116.27 | $140K | Direct | Dec 29, 2020 (1d) |
| Dec 21, 2020 | MRNA | ↓ Sell | 17,129 | $142.59 | $2.4M | Direct | Dec 22, 2020 (1d) |
| Dec 14, 2020 | MRNA | ↓ Sell | 25,034 | $157.81 | $4.0M | Direct | Dec 16, 2020 (2d) |
| Dec 7, 2020 | MRNA | ↓ Sell | 20,000 | $158.47 | $3.2M | Direct | Dec 9, 2020 (2d) |
| Nov 30, 2020 | MRNA | ↓ Sell | 20,000 | $147.76 | $3.0M | Direct | Dec 1, 2020 (1d) |
| Nov 23, 2020 | MRNA | ↓ Sell | 15,000 | $100.53 | $1.5M | Direct | Nov 24, 2020 (1d) |
| Nov 16, 2020 | MRNA | ↓ Sell | 15,000 | $96.99 | $1.5M | Direct | Nov 17, 2020 (1d) |
| Nov 9, 2020 | MRNA | ↓ Sell | 15,000 | $77.96 | $1.2M | Direct | Nov 10, 2020 (1d) |
| Nov 2, 2020 | MRNA | ↓ Sell | 15,000 | $67.17 | $1.0M | Direct | Nov 4, 2020 (2d) |
| Oct 26, 2020 | MRNA | ↓ Sell | 15,000 | $70.00 | $1.1M | Direct | Oct 27, 2020 (1d) |
| Oct 19, 2020 | MRNA | ↓ Sell | 15,000 | $71.94 | $1.1M | Direct | Oct 20, 2020 (1d) |
| Oct 12, 2020 | MRNA | ↓ Sell | 15,000 | $74.47 | $1.1M | Direct | Oct 13, 2020 (1d) |
| Oct 5, 2020 | MRNA | ↓ Sell | 15,000 | $70.24 | $1.1M | Direct | Oct 6, 2020 (1d) |
| Sep 28, 2020 | MRNA | ↓ Sell | 17,197 | $70.28 | $1.2M | Direct | Sep 29, 2020 (1d) |
| Sep 21, 2020 | MRNA | ↓ Sell | 20,000 | $67.30 | $1.3M | Direct | Sep 22, 2020 (1d) |
| Sep 14, 2020 | MRNA | ↓ Sell | 20,034 | $62.66 | $1.3M | Direct | Sep 15, 2020 (1d) |
| Sep 8, 2020 | MRNA | ↓ Sell | 26,467 | $56.20 | $1.5M | Direct | Sep 10, 2020 (2d) |
| Aug 31, 2020 | MRNA | ↓ Sell | 30,000 | $64.10 | $1.9M | Direct | Sep 1, 2020 (1d) |
| Aug 24, 2020 | MRNA | ↓ Sell | 25,000 | $64.99 | $1.6M | Direct | Aug 25, 2020 (1d) |
| Aug 17, 2020 | MRNA | ↓ Sell | 20,000 | $69.06 | $1.4M | Direct | Aug 18, 2020 (1d) |
| Aug 10, 2020 | MRNA | ↓ Sell | 20,000 | $74.27 | $1.5M | Direct | Aug 11, 2020 (1d) |
| Aug 3, 2020 | MRNA | ↓ Sell | 20,000 | $74.89 | $1.5M | Direct | Aug 4, 2020 (1d) |
| Jul 27, 2020 | MRNA | ↓ Sell | 20,000 | $78.73 | $1.6M | Direct | Jul 29, 2020 (2d) |
| Jul 20, 2020 | MRNA | ↓ Sell | 20,000 | $83.50 | $1.7M | Direct | Jul 21, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TEVA insiders
Open-market trades in the last 12 months
About Tal Zvi Zaks's insider trades
Tal Zvi Zaks is an insider at Teva Pharmaceutical Industries (TEVA). Since Dec 12, 2019, Tal has reported no open-market purchases and 72 sales worth $114.1M on SEC Form 4. In the last 12 months: 1 sale ($593).
Their filings also include option exercises (64 filings), grants and awards (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TEVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.